CEO John Hendrick on Zepto’s Fast Development

Mynosys Cellular Devices is developing Zepto, a disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a reproducible capsulotomy that is quick, safe, and affordable. Zepto consists of a silicon suction cup, a nitinol capsulotomy cutting element and an incision finder/push-rod system.

01:00 – The origin of the Zepto name.
01:19 – It can be used in every other cataract procedure.
01:43 – Zepto offers unique intraoperative tool.
02:20 – Where is Zepto in development.
02:40 – How do you swing a four-week clinical trial?
03:10 – What does Zepto deliver to the surgeon and patient?
03:50 – Do you need capital?

Speaking With:


John Hendrick

Mr. Hendrick has over three decades of executive experience, building both early stage medical device companies as well as large divisions in Medical device Corporations.

View Full Profile


Get the Latest News, Podcasts and Videos.